inputSequence,subtypeText,validationResults,alignedGeneSequences,drugResistance
{'header': 'U54771.CM240.CRF01_AE.0'},,[],"[{'firstAA': 1, 'lastAA': 560, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 6, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 11, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 238, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 286, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 291, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 292, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 312, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 326, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 329, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 335, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 357, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 358, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 359, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 366, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 371, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 375, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 390, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 395, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 400, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 403, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 432, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'N', 'position': 447, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 471, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 480, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 491, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 512, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 517, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 519, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 524, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 534, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 554, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'U31246.IND8.C.1'},,[],"[{'firstAA': 1, 'lastAA': 358, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 36, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 48, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 63, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 121, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 272, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 277, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 286, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 291, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 292, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 335, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF013429.143P21W104.B.2'},,[],"[{'firstAA': 26, 'lastAA': 243, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 28, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 68, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'YS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF013439.143P14W104.B.3'},,[],"[{'firstAA': 26, 'lastAA': 243, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF013449.143P3W104.B.4'},,[],"[{'firstAA': 26, 'lastAA': 243, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'L', 'position': 74, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'L74V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L74V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': -10.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': -10.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'L74V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': -10.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF013459.143P12W104.B.5'},,[],"[{'firstAA': 26, 'lastAA': 243, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 65, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 68, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 69, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 228, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 45.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': -15.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': -15.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'U83607.Z1624.C.6'},,[],"[{'firstAA': 26, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 36, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 48, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF090513.260Pt2BC.B.7'},,[],"[{'firstAA': 26, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF090527.260Pt7BC.B.8'},,[],"[{'firstAA': 30, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'ILV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'ILV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 64, 'AAs': 'KN', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF090471.260Pt12W8P.B.9'},,[],"[{'firstAA': 31, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'S', 'position': 68, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 82, 'AAs': 'KR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 103, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 140, 'AAs': 'TPAS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 158, 'AAs': 'AS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'IM', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Y', 'position': 181, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 204, 'AAs': 'ED', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'KN', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 45.0}], 'text': 'Intermediate Resistance'}]}]"
{'header': 'AF090484.260Pt17W8C.B.10'},,[],"[{'firstAA': 26, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 103, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 121, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Y', 'position': 181, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 45.0}], 'text': 'Intermediate Resistance'}]}]"
{'header': 'AF090499.260Pt23BC.B.11'},,[],"[{'firstAA': 26, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 104, 'AAs': 'KN', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 176, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF090509.260Pt28BC.B.12'},,[],"[{'firstAA': 26, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'T', 'position': 27, 'AAs': 'X', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF021291.JIDP4W104.B.13'},,[],"[{'firstAA': 26, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 104, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 131, 'AAs': 'TP', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'KQE*', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF021270.JIDP25W0.B.14'},,[],"[{'firstAA': 26, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 28, 'AAs': 'EAGV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 48, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'MV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF021275.JIDP16W0.B.15'},,[],"[{'firstAA': 26, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 220, 'AAs': 'X', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 241, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF021280.JIDP7W0.B.16'},,[],"[{'firstAA': 26, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'C', 'position': 38, 'AAs': 'YSCF', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 131, 'AAs': 'TP', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'X', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 220, 'AAs': 'X', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 241, 'AAs': 'EAGV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF021312.JIDP20W104.B.17'},,[],"[{'firstAA': 26, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 44, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 158, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 241, 'AAs': 'EAGV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 125.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 135.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 110.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 30.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF009374.92BR020.B.18'},,[],"[{'firstAA': 1, 'lastAA': 298, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 32, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 283, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 292, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF009410.92RW026.C.19'},,[],"[{'firstAA': 1, 'lastAA': 298, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 97, 'AAs': 'X', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'X', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 126, 'AAs': 'X', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 158, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'X', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 272, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 286, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 292, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 294, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF009391.92TH021.CRF01_AE.20'},,[],"[{'firstAA': 1, 'lastAA': 269, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 6, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 11, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 238, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF009401.92UG046.D.21'},,[],"[{'firstAA': 1, 'lastAA': 298, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 8, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 40, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 48, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 49, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 121, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 250, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 272, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 276, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 277, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 282, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 283, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 286, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'L20571.MVP5180.O.22'},,[],"[{'firstAA': 1, 'lastAA': 560, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 6, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 7, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 27, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 28, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 32, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 36, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 49, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 102, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 103, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 104, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 169, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'E', 'position': 194, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 195, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 197, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 201, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 204, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 248, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 250, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 251, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 272, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 275, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 278, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 283, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 288, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 296, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 297, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 304, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 309, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 320, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 322, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 326, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 327, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 328, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 332, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 334, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 341, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 344, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 345, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 346, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 357, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 358, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 359, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 360, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 365, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 366, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 369, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 371, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 375, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 376, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 377, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 379, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 386, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 390, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 393, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 394, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 395, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 400, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 403, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'N', 'position': 418, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 423, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 431, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 449, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 460, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 461, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 463, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 465, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 466, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 467, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 468, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 470, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 471, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 477, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 480, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 482, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'H', 'position': 483, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 484, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 490, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 491, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 492, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 502, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 507, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 508, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 511, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 512, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 514, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 516, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 517, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 519, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 524, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 526, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 530, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 534, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 547, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 548, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 554, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 555, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 558, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'M184I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': -10.0, 'partialScores': [{'mutations': [{'text': 'M184I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': -10.0, 'partialScores': [{'mutations': [{'text': 'M184I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'M184I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M184I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M184I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': -10.0, 'partialScores': [{'mutations': [{'text': 'M184I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 30.0}, {'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}]}]"
{'header': 'AF021282.JIDP29W0.B.23'},,[],"[{'firstAA': 26, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 241, 'AAs': 'EAGV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'Y14500.BCF07.O.24'},,[],"[{'firstAA': 1, 'lastAA': 265, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'P', 'position': 4, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 6, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 7, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 21, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 27, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 28, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 32, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 36, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 49, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 102, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 104, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 106, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 126, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 169, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Y', 'position': 181, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 194, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 195, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 197, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 201, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 204, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 248, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 250, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 251, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 261, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V106I', 'primaryType': 'Other', 'comments': [{'type': 'Other', 'text': 'V106I is occurs in 1% to 2% of viruses from untreated persons. It contributes to reduced NNRTI susceptibility in combination with other mutations. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score despite not contributing much to reduced ETR susceptibility. It likely plays a greater role in reducing DOR susceptibility, particularly in combination with other NNRTI-associated DRMs. '}]}], 'score': 15.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}, {'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'V106I', 'primaryType': 'Other', 'comments': [{'type': 'Other', 'text': 'V106I is occurs in 1% to 2% of viruses from untreated persons. It contributes to reduced NNRTI susceptibility in combination with other mutations. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score despite not contributing much to reduced ETR susceptibility. It likely plays a greater role in reducing DOR susceptibility, particularly in combination with other NNRTI-associated DRMs. '}]}], 'score': 10.0}, {'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}, {'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 115.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 30.0}, {'mutations': [{'text': 'V106I', 'primaryType': 'Other', 'comments': [{'type': 'Other', 'text': 'V106I is occurs in 1% to 2% of viruses from untreated persons. It contributes to reduced NNRTI susceptibility in combination with other mutations. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score despite not contributing much to reduced ETR susceptibility. It likely plays a greater role in reducing DOR susceptibility, particularly in combination with other NNRTI-associated DRMs. '}]}], 'score': 10.0}, {'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 85.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V106I', 'primaryType': 'Other', 'comments': [{'type': 'Other', 'text': 'V106I is occurs in 1% to 2% of viruses from untreated persons. It contributes to reduced NNRTI susceptibility in combination with other mutations. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score despite not contributing much to reduced ETR susceptibility. It likely plays a greater role in reducing DOR susceptibility, particularly in combination with other NNRTI-associated DRMs. '}]}], 'score': 10.0}, {'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 45.0}, {'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}]}]"
{'header': 'AF005495.93BR029.B.25'},,[],"[{'firstAA': 1, 'lastAA': 560, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 20, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 277, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 297, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 346, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 376, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 386, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 403, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 468, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 515, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 517, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 519, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 531, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 554, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'Y16145.RO-BCI18.F.26'},,[],"[{'firstAA': 33, 'lastAA': 232, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 40, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF047281.1-197.B.27'},,[],"[{'firstAA': 1, 'lastAA': 278, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 20, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 21, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 44, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 102, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 205, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'H', 'position': 208, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 224, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 272, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 125.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 125.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AY802588.CA10381.B.28'},,[],"[{'firstAA': 1, 'lastAA': 286, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'Z99324.C31B.B.29'},,[],"[{'firstAA': 1, 'lastAA': 260, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'D', 'position': 67, 'AAs': 'NI', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 70, 'AAs': '*', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'TS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215S', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215S', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 20.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215S', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 20.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215S', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215S', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'Z99333.C43W24.B.30'},,[],"[{'firstAA': 1, 'lastAA': 260, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'T', 'position': 39, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 49, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'Z99319.C25W24.B.31'},,[],"[{'firstAA': 1, 'lastAA': 260, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'KI', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'Z99303.C7W24.B.32'},,[],"[{'firstAA': 1, 'lastAA': 260, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 16, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 104, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 164, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 194, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 105.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 20.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 135.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'L39039.HSM1423.B.33'},,[],"[{'firstAA': 7, 'lastAA': 223, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 20, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 32, 'AAs': 'KRIM', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 33, 'AAs': 'EAGV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 139, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'L39032.IVDAB197.B.34'},,[],"[{'firstAA': 7, 'lastAA': 223, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'R', 'position': 83, 'AAs': 'KE', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF096884.jci-4-897.B.35'},,[],"[{'firstAA': 1, 'lastAA': 254, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 6, 'AAs': 'ED', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 69, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'W', 'position': 88, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF056640.Orl2-W56.F.36'},,[],"[{'firstAA': 3, 'lastAA': 221, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 169, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF056650.Orl5-W64.B.37'},,[],"[{'firstAA': 3, 'lastAA': 221, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 49, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 55, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 165, 'AAs': 'TI', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'NTYS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF056660.Orl7-W130.B.38'},,[],"[{'firstAA': 3, 'lastAA': 221, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'ND', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 104, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'TISF', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 115.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 100.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF056670.Orl17-W224.B.39'},,[],"[{'firstAA': 3, 'lastAA': 221, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'T', 'position': 39, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 103, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 214, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 50.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF056679.Orl21-W300.B.40'},,[],"[{'firstAA': 3, 'lastAA': 221, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'T', 'position': 39, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 85.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T215V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 20.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 20.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AY802593.CA10424.B.41'},,[],"[{'firstAA': 1, 'lastAA': 261, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 75, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 104, 'AAs': 'KN', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'H', 'position': 208, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 218, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 228, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 248, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 130.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'V75M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75M causes intermediate d4T resistance, low-level ddI resistance, and potentially low-level AZT resistance.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219W is an uncommon NRTI-selected mutation.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 145.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V75M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75M causes intermediate d4T resistance, low-level ddI resistance, and potentially low-level AZT resistance.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219W is an uncommon NRTI-selected mutation.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 30.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'V75M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75M causes intermediate d4T resistance, low-level ddI resistance, and potentially low-level AZT resistance.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219W is an uncommon NRTI-selected mutation.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AY802602.CA10382.B.42'},,[],"[{'firstAA': 1, 'lastAA': 261, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AY802603.CA23587.B.43'},,[],"[{'firstAA': 1, 'lastAA': 300, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'A', 'position': 62, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 68, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 69, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 75, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 77, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 108, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Y', 'position': 115, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 116, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 151, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Y', 'position': 181, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'H', 'position': 221, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 228, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 238, 'AAs': 'KT', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 277, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 185.0, 'partialScores': [{'mutations': [{'text': 'A62V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'A62V is an accessory mutation that often occurs in combination with the multi-NRTI resistance mutations K65R or Q151M. A62V is widespread in subtype A viruses in former Soviet Union countries but A62 is otherwise non-polymorphic.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'Y115F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Y115F causes intermediate resistance to ABC and low-level resistance to TDF.'}]}], 'score': 60.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'A62V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'A62V is an accessory mutation that often occurs in combination with the multi-NRTI resistance mutations K65R or Q151M. A62V is widespread in subtype A viruses in former Soviet Union countries but A62 is otherwise non-polymorphic.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': -10.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 125.0, 'partialScores': [{'mutations': [{'text': 'A62V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'A62V is an accessory mutation that often occurs in combination with the multi-NRTI resistance mutations K65R or Q151M. A62V is widespread in subtype A viruses in former Soviet Union countries but A62 is otherwise non-polymorphic.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 125.0, 'partialScores': [{'mutations': [{'text': 'A62V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'A62V is an accessory mutation that often occurs in combination with the multi-NRTI resistance mutations K65R or Q151M. A62V is widespread in subtype A viruses in former Soviet Union countries but A62 is otherwise non-polymorphic.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'A62V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'A62V is an accessory mutation that often occurs in combination with the multi-NRTI resistance mutations K65R or Q151M. A62V is widespread in subtype A viruses in former Soviet Union countries but A62 is otherwise non-polymorphic.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 10.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 5.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'A62V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'A62V is an accessory mutation that often occurs in combination with the multi-NRTI resistance mutations K65R or Q151M. A62V is widespread in subtype A viruses in former Soviet Union countries but A62 is otherwise non-polymorphic.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 10.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 5.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'A62V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'A62V is an accessory mutation that often occurs in combination with the multi-NRTI resistance mutations K65R or Q151M. A62V is widespread in subtype A viruses in former Soviet Union countries but A62 is otherwise non-polymorphic.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'Y115F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Y115F causes intermediate resistance to ABC and low-level resistance to TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 5.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'V108I', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V108I is a relatively non-polymorphic accessory mutation selected in vitro and/or in vivo with each of the NNRTIs. It causes low-level reductions in susceptibility to NVP and DOR. Alone, it does not appear to reduce susceptibility to EFV, ETR, or RPV.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'H221Y', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'H221Y is a non-polymorphic accessory mutation selected primarily by NVP and RPV. It frequently occurs in combination with Y181C.'}]}], 'score': 10.0}, {'mutations': [{'text': 'V108I', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V108I is a relatively non-polymorphic accessory mutation selected in vitro and/or in vivo with each of the NNRTIs. It causes low-level reductions in susceptibility to NVP and DOR. Alone, it does not appear to reduce susceptibility to EFV, ETR, or RPV.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'V108I', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V108I is a relatively non-polymorphic accessory mutation selected in vitro and/or in vivo with each of the NNRTIs. It causes low-level reductions in susceptibility to NVP and DOR. Alone, it does not appear to reduce susceptibility to EFV, ETR, or RPV.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}, {'mutations': [{'text': 'H221Y', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'H221Y is a non-polymorphic accessory mutation selected primarily by NVP and RPV. It frequently occurs in combination with Y181C.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K238T', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K238T is a non-polymorphic mutation selected in patients receiving NVP and EFV. It usually occurs in combination with K103N. It reduces susceptibility to NVP and EFV by about 5-fold. It may also reduce susceptibility to ETR and RPV. K238N is a non-polymorphic accessory mutation that is also selected by NVP and EFV. It appears to have minimal, if any, effects on NNRTI susceptibility.'}]}], 'score': 30.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}, {'mutations': [{'text': 'H221Y', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'H221Y is a non-polymorphic accessory mutation selected primarily by NVP and RPV. It frequently occurs in combination with Y181C.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'V108I', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V108I is a relatively non-polymorphic accessory mutation selected in vitro and/or in vivo with each of the NNRTIs. It causes low-level reductions in susceptibility to NVP and DOR. Alone, it does not appear to reduce susceptibility to EFV, ETR, or RPV.'}]}], 'score': 15.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'H221Y', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'H221Y is a non-polymorphic accessory mutation selected primarily by NVP and RPV. It frequently occurs in combination with Y181C.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K238T', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K238T is a non-polymorphic mutation selected in patients receiving NVP and EFV. It usually occurs in combination with K103N. It reduces susceptibility to NVP and EFV by about 5-fold. It may also reduce susceptibility to ETR and RPV. K238N is a non-polymorphic accessory mutation that is also selected by NVP and EFV. It appears to have minimal, if any, effects on NNRTI susceptibility.'}]}], 'score': 30.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 45.0}, {'mutations': [{'text': 'H221Y', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'H221Y is a non-polymorphic accessory mutation selected primarily by NVP and RPV. It frequently occurs in combination with Y181C.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}]}]"
{'header': 'AF088122.CA3186.B.44'},,[],"[{'firstAA': 1, 'lastAA': 279, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'A', 'position': 33, 'AAs': 'PA', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 37, 'AAs': 'TI', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'KE', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 48, 'AAs': 'PS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 106, 'AAs': 'AV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'KE', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 190, 'AAs': 'AG', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'EG', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 218, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 272, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 277, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 105.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 20.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 135.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 130.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 30.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'V106A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V106A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It is selected in vitro and in vivo by DOR and alone it causes intermediate reductions in DOR susceptibility. In combination with other DOR-associated DRMs it is associated with high-level DOR resistance.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'V106A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V106A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It is selected in vitro and in vivo by DOR and alone it causes intermediate reductions in DOR susceptibility. In combination with other DOR-associated DRMs it is associated with high-level DOR resistance.'}]}], 'score': 45.0}, {'mutations': [{'text': 'G190A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility.'}]}], 'score': 45.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'G190A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'V106A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V106A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It is selected in vitro and in vivo by DOR and alone it causes intermediate reductions in DOR susceptibility. In combination with other DOR-associated DRMs it is associated with high-level DOR resistance.'}]}], 'score': 60.0}, {'mutations': [{'text': 'G190A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'G190A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}]}]"
{'header': 'AF088114.CA3164.B.45'},,[],"[{'firstAA': 1, 'lastAA': 285, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 20, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 102, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 214, 'AAs': 'LF', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 272, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 278, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 20.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 105.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF088082.CA3099.B.46'},,[],"[{'firstAA': 1, 'lastAA': 299, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'T', 'position': 27, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 31, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 64, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 195, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 218, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 228, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 248, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 249, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 288, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 20.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF088127.CA3048.B.47'},,[],"[{'firstAA': 1, 'lastAA': 304, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'ND', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'W', 'position': 88, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 277, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 286, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 291, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 299, 'AAs': 'AG', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AY802612.CA10470.B.48'},,[],"[{'firstAA': 1, 'lastAA': 240, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 44, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 74, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 109, 'AAs': 'IL', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 190, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'H', 'position': 208, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'TPAS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 216, 'AAs': 'TPAS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 228, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 230, 'AAs': 'MV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 30.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 135.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 20.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 20.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 140.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'G190S', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190S is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. Preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'G190S', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190S is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. Preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'G190S', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190S is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. Preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'G190S', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190S is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. Preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'G190S', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190S is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. Preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}]}]"
{'header': 'AY802621.CA9353.B.49'},,[],"[{'firstAA': 1, 'lastAA': 260, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 44, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'W', 'position': 88, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'AG', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 103, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 106, 'AAs': 'AV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'KE', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 189, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'TA', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 203, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'H', 'position': 208, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'ND', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'H', 'position': 221, 'AAs': 'HY', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 226, 'AAs': 'PS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 243, 'AAs': 'HP', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 115.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 125.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 85.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V106A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V106A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It is selected in vitro and in vivo by DOR and alone it causes intermediate reductions in DOR susceptibility. In combination with other DOR-associated DRMs it is associated with high-level DOR resistance.'}]}], 'score': 60.0}, {'mutations': [{'text': 'H221Y', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'H221Y is a non-polymorphic accessory mutation selected primarily by NVP and RPV. It frequently occurs in combination with Y181C.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 130.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'V106A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V106A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It is selected in vitro and in vivo by DOR and alone it causes intermediate reductions in DOR susceptibility. In combination with other DOR-associated DRMs it is associated with high-level DOR resistance.'}]}], 'score': 45.0}, {'mutations': [{'text': 'H221Y', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'H221Y is a non-polymorphic accessory mutation selected primarily by NVP and RPV. It frequently occurs in combination with Y181C.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'H221Y', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'H221Y is a non-polymorphic accessory mutation selected primarily by NVP and RPV. It frequently occurs in combination with Y181C.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 165.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 30.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'V106A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V106A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It is selected in vitro and in vivo by DOR and alone it causes intermediate reductions in DOR susceptibility. In combination with other DOR-associated DRMs it is associated with high-level DOR resistance.'}]}], 'score': 60.0}, {'mutations': [{'text': 'H221Y', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'H221Y is a non-polymorphic accessory mutation selected primarily by NVP and RPV. It frequently occurs in combination with Y181C.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'H221Y', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'H221Y is a non-polymorphic accessory mutation selected primarily by NVP and RPV. It frequently occurs in combination with Y181C.'}]}], 'score': 15.0}], 'text': 'Intermediate Resistance'}]}]"
{'header': 'AY802640.CA9230.B.50'},,[],"[{'firstAA': 1, 'lastAA': 279, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'KQ', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 44, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 68, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 75, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 103, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Y', 'position': 181, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 203, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'N', 'position': 265, 'AAs': 'NT', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 272, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 276, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 100.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 135.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'V75M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75M causes intermediate d4T resistance, low-level ddI resistance, and potentially low-level AZT resistance.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 155.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'V75M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75M causes intermediate d4T resistance, low-level ddI resistance, and potentially low-level AZT resistance.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 115.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'V75M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75M causes intermediate d4T resistance, low-level ddI resistance, and potentially low-level AZT resistance.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 110.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}, {'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}, {'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 155.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 30.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 45.0}, {'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}]}]"
{'header': 'AY802650.CA3732.B.51'},,[],"[{'firstAA': 1, 'lastAA': 303, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 20, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 44, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 190, 'AAs': 'AG', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 203, 'AAs': 'KE', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'H', 'position': 208, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 257, 'AAs': 'IL', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 283, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 284, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 297, 'AAs': 'EA', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 100.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 130.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 130.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 100.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219N/R are accessory TAMS that usually occur in combination with multiple other TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'G190A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility.'}]}], 'score': 45.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'G190A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'G190A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'G190A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190A is a non-polymorphic mutation that causes high-level resistance to NVP and intermediate resistance to EFV. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. It also does not appear to reduce DOR susceptibility.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}]}]"
{'header': 'AY802660.CA9940.B.52'},,[],"[{'firstAA': 1, 'lastAA': 251, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 6, 'AAs': 'DE', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'EV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AY802669.CA9954.B.53'},,[],"[{'firstAA': 1, 'lastAA': 303, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 40, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 68, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 74, 'AAs': 'IL', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 104, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'ED', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 228, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 286, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 291, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 297, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 145.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'E40F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E40F is a non-polymorphic accessory mutation selected by AZT and d4T. It usually occurs in combination with M41L, L210W and T215Y. In this context it is associated with reduced susceptibility to each of the NRTIs.'}]}, {'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 125.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'E40F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E40F is a non-polymorphic accessory mutation selected by AZT and d4T. It usually occurs in combination with M41L, L210W and T215Y. In this context it is associated with reduced susceptibility to each of the NRTIs.'}]}, {'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 125.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'E40F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E40F is a non-polymorphic accessory mutation selected by AZT and d4T. It usually occurs in combination with M41L, L210W and T215Y. In this context it is associated with reduced susceptibility to each of the NRTIs.'}]}, {'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 160.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'E40F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E40F is a non-polymorphic accessory mutation selected by AZT and d4T. It usually occurs in combination with M41L, L210W and T215Y. In this context it is associated with reduced susceptibility to each of the NRTIs.'}]}, {'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'E40F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E40F is a non-polymorphic accessory mutation selected by AZT and d4T. It usually occurs in combination with M41L, L210W and T215Y. In this context it is associated with reduced susceptibility to each of the NRTIs.'}]}, {'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219E', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF124547.SD-12.B.54'},,[],"[{'firstAA': 1, 'lastAA': 306, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 224, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 272, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 20.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 105.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 100.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 95.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 30.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF169046.Vent3B.B.55'},,[],"[{'firstAA': 30, 'lastAA': 230, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'KE', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF169058.Vent9B.B.56'},,[],"[{'firstAA': 30, 'lastAA': 230, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 228, 'AAs': 'HL', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 50.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF169068.Vent14B.B.57'},,[],"[{'firstAA': 30, 'lastAA': 230, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 53, 'AAs': 'QE', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 72, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF169083.Vent21W24.B.58'},,[],"[{'firstAA': 30, 'lastAA': 230, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 79, 'AAs': 'EV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}]}]"
{'header': 'AF169093.Vent26W24.B.59'},,[],"[{'firstAA': 30, 'lastAA': 230, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 44, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF169105.Vent32W24.B.60'},,[],"[{'firstAA': 30, 'lastAA': 230, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'S', 'position': 48, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 69, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 214, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF169115.Vent37W24.B.61'},,[],"[{'firstAA': 30, 'lastAA': 230, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'ML', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 42, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'ED', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'MV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 203, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AJ239233.DRO3M12.CRF02_AG.62'},,[],"[{'firstAA': 20, 'lastAA': 231, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 36, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'ML', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 86, 'AAs': 'ED', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 161, 'AAs': 'QH', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AJ239250.DRO12B.B.63'},,[],"[{'firstAA': 20, 'lastAA': 231, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 44, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'H', 'position': 208, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 105.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 105.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44A', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AJ239260.DRO17B.B.64'},,[],"[{'firstAA': 20, 'lastAA': 231, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 49, 'AAs': 'KR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 138, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 140, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 100.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 100.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'E138A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'E138A is a common polymorphic accessory mutation weakly selected in patients receiving ETR and RPV. It reduces ETR and RPV susceptibility ~2-fold. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'E138A', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'E138A is a common polymorphic accessory mutation weakly selected in patients receiving ETR and RPV. It reduces ETR and RPV susceptibility ~2-fold. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}]}]"
{'header': 'AJ239272.DRO23B.B.65'},,[],"[{'firstAA': 20, 'lastAA': 231, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 28, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 36, 'AAs': 'QE', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 44, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 46, 'AAs': 'KQ', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 49, 'AAs': 'KT', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 143, 'AAs': 'TR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF102336.C0.B.66'},,[],"[{'firstAA': 39, 'lastAA': 239, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 64, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 115.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 100.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF102346.F19.B.67'},,[],"[{'firstAA': 39, 'lastAA': 239, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 110.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 95.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF102356.H58.B.68'},,[],"[{'firstAA': 39, 'lastAA': 239, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 74, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 103, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 107, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Y', 'position': 181, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 228, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 135.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L74V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}, {'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 45.0}], 'text': 'Intermediate Resistance'}]}]"
{'header': 'AF102366.L0.B.69'},,[],"[{'firstAA': 39, 'lastAA': 239, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'T', 'position': 39, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 65, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 68, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 69, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 75, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 77, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 102, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 116, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 151, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 140.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 45.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': -15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 170.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 60.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 165.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 60.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 30.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 5.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 30.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 5.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 120.0, 'partialScores': [{'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}], 'score': 60.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'V75I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75I is a relatively non-polymorphic accessory mutation that often occurs in combination with the multi-NRTI resistance mutation Q151M. When V75I occurs alone its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}], 'score': 5.0}, {'mutations': [{'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}], 'score': 5.0}, {'mutations': [{'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K65R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K65R causes intermediate/high-level resistance to TDF, ddI, ABC and d4T and low/intermediate resistance to 3TC and FTC. K65R increases susceptibility to AZT.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 10.0}, {'mutations': [{'text': 'F77L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F77L usually occurs in combination with the multi-NRTI resistance mutation Q151M. When it occurs alone, its clinical significance is uncertain.'}]}, {'text': 'F116Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'F116Y usually occurs in combination with the multi-NRTI resistance mutation Q151M.'}]}, {'text': 'Q151M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Q151M causes intermediate/high-level resistance to AZT, ddI, d4T and ABC and low-level resistance to TDF, 3TC and FTC. In combination with accessory mutations at positions 62, 75, 77, and 116, Q151M confers high-level resistance to AZT, ddI, d4T and ABC and intermediate resistance to TDF, 3TC and FTC.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF153376.MilazzoCH1.B.70'},,[],"[{'firstAA': 1, 'lastAA': 234, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 20, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 28, 'AAs': 'ED', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'NHD', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 214, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 50.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 50.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF153386.MilazzoLU1.B.71'},,[],"[{'firstAA': 1, 'lastAA': 234, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 102, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF153397.MilazzoTA0.B.72'},,[],"[{'firstAA': 1, 'lastAA': 234, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'R', 'position': 72, 'AAs': 'RG', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 158, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 169, 'AAs': 'ED', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'KR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'TA', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF153407.MilazzoZG0.B.73'},,[],"[{'firstAA': 1, 'lastAA': 234, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'T', 'position': 7, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 128, 'AAs': 'TS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 115.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 100.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF188342.HolgHC12.CRF02_AG.74'},,[],"[{'firstAA': 5, 'lastAA': 283, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 36, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 49, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 275, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 276, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF177543.BPG108.448.A.75'},,[],"[{'firstAA': 1, 'lastAA': 321, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 50, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'AS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 248, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 286, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 288, 'AAs': 'AS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 292, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 312, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF177368.BPG190-574.A.76'},,[],"[{'firstAA': 1, 'lastAA': 315, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 40, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 158, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 165, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'SL', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 250, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 291, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 297, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 312, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF177375.BPG326-662.D.77'},,[],"[{'firstAA': 1, 'lastAA': 315, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 36, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 49, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 165, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'IMV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 216, 'AAs': 'TA', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 250, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 272, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 277, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 282, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 286, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 288, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 292, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 293, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF158751.V2000-2P.B.78'},,[],"[{'firstAA': 30, 'lastAA': 227, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF158789.V2000-24P.B.79'},,[],"[{'firstAA': 30, 'lastAA': 227, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'G', 'position': 45, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 50, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 70, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 20.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 20.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70E/G cause low-level resistance to TDF, ABC, DDI and possibly 3TC and FTC. K70E/G increase susceptibility to AZT.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y/F cause intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF. T215S/C/D/E/I/V/N/A/L do not reduce NRTI susceptibility but arise from viruses that once contained T215Y/F. The presence of one of these revertant mutations suggests that the patient may have once had a majority virus population with T215Y/F.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF227710.JF02-8w.B.80'},,[],"[{'firstAA': 15, 'lastAA': 267, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 20, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 48, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 52, 'AAs': 'NTHP', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 55, 'AAs': 'KTQP', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 59, 'AAs': 'TP', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': '-', 'isInsertion': False, 'isDeletion': True, 'isApobecDRM': False}, {'consensus': 'T', 'position': 69, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 74, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 75, 'AAs': 'TA', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 103, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 228, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 145.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67Deletion', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Amino acid deletions between codons 67 and 70 are rare and usually occur in combination with multiple TAMs, K65R, or the Q151M mutation complex. Deletions at position 67 are more often associated with multiple TAMs. Deletions at positions 69 and 70 are more often associated with K65R or the Q151M mutation complex.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T69G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69G is a rare non-polymorphic mutation that usually occurs in viruses with a deletion at codon 67 and multiple other NRTI-resistance mutations.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 135.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67Deletion', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Amino acid deletions between codons 67 and 70 are rare and usually occur in combination with multiple TAMs, K65R, or the Q151M mutation complex. Deletions at position 67 are more often associated with multiple TAMs. Deletions at positions 69 and 70 are more often associated with K65R or the Q151M mutation complex.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T69G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69G is a rare non-polymorphic mutation that usually occurs in viruses with a deletion at codon 67 and multiple other NRTI-resistance mutations.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 185.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67Deletion', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Amino acid deletions between codons 67 and 70 are rare and usually occur in combination with multiple TAMs, K65R, or the Q151M mutation complex. Deletions at position 67 are more often associated with multiple TAMs. Deletions at positions 69 and 70 are more often associated with K65R or the Q151M mutation complex.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T69G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69G is a rare non-polymorphic mutation that usually occurs in viruses with a deletion at codon 67 and multiple other NRTI-resistance mutations.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'V75T', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75T causes high-level d4T resistance and intermediate ddI resistance.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 195.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67Deletion', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Amino acid deletions between codons 67 and 70 are rare and usually occur in combination with multiple TAMs, K65R, or the Q151M mutation complex. Deletions at position 67 are more often associated with multiple TAMs. Deletions at positions 69 and 70 are more often associated with K65R or the Q151M mutation complex.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T69G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69G is a rare non-polymorphic mutation that usually occurs in viruses with a deletion at codon 67 and multiple other NRTI-resistance mutations.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'V75T', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75T causes high-level d4T resistance and intermediate ddI resistance.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'D67Deletion', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Amino acid deletions between codons 67 and 70 are rare and usually occur in combination with multiple TAMs, K65R, or the Q151M mutation complex. Deletions at position 67 are more often associated with multiple TAMs. Deletions at positions 69 and 70 are more often associated with K65R or the Q151M mutation complex.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'D67Deletion', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Amino acid deletions between codons 67 and 70 are rare and usually occur in combination with multiple TAMs, K65R, or the Q151M mutation complex. Deletions at position 67 are more often associated with multiple TAMs. Deletions at positions 69 and 70 are more often associated with K65R or the Q151M mutation complex.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67Deletion', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'Amino acid deletions between codons 67 and 70 are rare and usually occur in combination with multiple TAMs, K65R, or the Q151M mutation complex. Deletions at position 67 are more often associated with multiple TAMs. Deletions at positions 69 and 70 are more often associated with K65R or the Q151M mutation complex.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T69G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69G is a rare non-polymorphic mutation that usually occurs in viruses with a deletion at codon 67 and multiple other NRTI-resistance mutations.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 30.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}]}]"
{'header': 'AF227720.JF08-12w.B.81'},,[],"[{'firstAA': 24, 'lastAA': 261, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 64, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 69, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 74, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 171, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 204, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 214, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 228, 'AAs': 'HL', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 150.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 20.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 130.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 115.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 150.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L74I', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L74V/I cause high-level resistance to ddI and intermediate resistance to ABC.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67G', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF. D67G/E/S/T/H are non-polymorphic NRTI-selected mutations that also generally occur in viruses with multiple TAMs.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF204050.CE97R102.F.82'},,[],"[{'firstAA': 1, 'lastAA': 290, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 173, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 182, 'AAs': 'QH', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 272, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 286, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF068954.ESP2-M17.O.83'},,[],"[{'firstAA': 28, 'lastAA': 220, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 28, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 32, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 36, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 43, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 78, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'W', 'position': 88, 'AAs': '*', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 102, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 104, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 128, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'N', 'position': 137, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 154, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 169, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Y', 'position': 181, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 194, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 195, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 197, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 201, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 203, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 204, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'V179E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'V179D is a polymorphic accessory NNRTI-selected mutation. It contributes low-levels reductions in susceptibility to each of the NNRTIs. The combination of V179D and K103R act synergistically to reduce NVP and EFV susceptibility. V179D has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. V179E is a non-polymorphic mutation occasionally selected by NVP and EFV. V179E appears similar to V179D in its effects on NNRTIs. V179D/E do not appear to reduce the virological response to a first-line EFV-containing regimen.'}]}], 'score': 10.0}, {'mutations': [{'text': 'Y181C', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'Y181C is a non-polymorphic mutation selected in patients receiving NVP, ETR and RPV. It reduces susceptibility to NVP, ETR, RPV, and EFV by >50-fold, 5-fold, 3-fold, and 2-fold, respectively. Although Y181C itself reduces EFV susceptibility by only 2-fold, it has been associated with a reduced response to an EFV-containing regimen in NNRTI-experienced patients. Y181C has a weight of 2.5 in the Tibotec ETR genotypic susceptibility score. Alone, it does not appear to reduce DOR susceptibility.'}]}], 'score': 45.0}], 'text': 'Intermediate Resistance'}]}]"
{'header': 'AF136800.Brp066.B.84'},,[],"[{'firstAA': 36, 'lastAA': 226, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 36, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 76, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 121, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 126, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 214, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 216, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'H', 'position': 221, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF251956.CB-132.B.85'},,[],"[{'firstAA': 1, 'lastAA': 244, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 64, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 90, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 150, 'AAs': 'PS', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 154, 'AAs': 'KE', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 161, 'AAs': 'QP', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 164, 'AAs': 'MI', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 20.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF251965.CB-145.B.86'},,[],"[{'firstAA': 1, 'lastAA': 245, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'T', 'position': 39, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 44, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 107, 'AAs': 'TP', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'KR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 115.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 115.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF251975.CB-159.B.87'},,[],"[{'firstAA': 1, 'lastAA': 233, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'V', 'position': 35, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'V', 'position': 90, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 203, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 223, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 85.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 110.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 110.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 85.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF251983.CB-170.B.88'},,[],"[{'firstAA': 1, 'lastAA': 249, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 28, 'AAs': 'KE', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF251987.CB-186.B.89'},,[],"[{'firstAA': 1, 'lastAA': 242, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 13, 'AAs': 'NK', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 31, 'AAs': 'IL', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 50, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 66, 'AAs': 'KR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 194, 'AAs': 'EG', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 20.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 105.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF252052.CB-199.B.90'},,[],"[{'firstAA': 1, 'lastAA': 236, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 49, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 75, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 102, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 197, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'V75M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75M causes intermediate d4T resistance, low-level ddI resistance, and potentially low-level AZT resistance.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'V75M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75M causes intermediate d4T resistance, low-level ddI resistance, and potentially low-level AZT resistance.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'V75M', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'V75M causes intermediate d4T resistance, low-level ddI resistance, and potentially low-level AZT resistance.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 0.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF252065.CB-212.B.91'},,[],"[{'firstAA': 1, 'lastAA': 252, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 20, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'T', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 179, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 214, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'F', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 228, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 242, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 245, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 115.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 110.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 85.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 30.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215F', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215F is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}]}]"
{'header': 'AF252081.CB-226.B.92'},,[],"[{'firstAA': 1, 'lastAA': 245, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 20, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 174, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 202, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'F', 'position': 214, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 20.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF251974.CB-242.B.93'},,[],"[{'firstAA': 1, 'lastAA': 249, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'T', 'position': 7, 'AAs': 'P', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 135, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 162, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'MV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'RG', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'X', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 20.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF252053.CB-252.B.94'},,[],"[{'firstAA': 1, 'lastAA': 235, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'L', 'position': 12, 'AAs': 'LF', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 35, 'AAs': 'MV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 39, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 50, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 60, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'K', 'position': 70, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'W', 'position': 88, 'AAs': 'C', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 104, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 80.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 155.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 140.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF251997.CB-265.B.95'},,[],"[{'firstAA': 1, 'lastAA': 246, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'E', 'position': 28, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 32, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'E', 'position': 44, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'D', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'A', 'position': 98, 'AAs': 'G', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 103, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 142, 'AAs': 'TI', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'H', 'position': 208, 'AAs': 'HY', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 125.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 135.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 110.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T69D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T69D is a non-polymorphic mutation that reduces susceptibility to ddI and possibly d4T.'}]}], 'score': 30.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 20.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'E44D', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'E44D is a relatively non-polymorphic accessory mutation and E44A is a nonpolymorphic accessory mutation. Each usually occurs with multiple TAMs.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 75.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 90.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 30.0}, {'mutations': [{'text': 'K103N', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K103N is a non-polymorphic mutation that causes high-level reductions in NVP and EFV susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'A98G', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'A98G is a non-polymorphic accessory mutation associated with low-level reduced susceptibility to each of the NNRTIs.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}]}]"
{'header': 'AF251947.CB-280.B.96'},,[],"[{'firstAA': 1, 'lastAA': 248, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 11, 'AAs': 'X', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 22, 'AAs': 'KTR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'V', 'position': 118, 'AAs': 'IV', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 166, 'AAs': 'KR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 196, 'AAs': 'EG', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'L', 'position': 210, 'AAs': 'W', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 100.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 100.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'L210W', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'L210W is a TAM that usually occurs in combination with M41L and T215Y. The combination of M41, L210W and T215Y causes high-level resistance to AZT and d4T and intermediate to high-level resistance to ddI, ABC and TDF.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AF252031.CB-297.B.97'},,[],"[{'firstAA': 1, 'lastAA': 242, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'M', 'position': 41, 'AAs': 'L', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 48, 'AAs': 'A', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'S', 'position': 68, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 69, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 102, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 122, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'P', 'position': 133, 'AAs': 'PR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 185, 'AAs': 'ED', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'G', 'position': 190, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 215, 'AAs': 'Y', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 65.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 15.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 40.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 35.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 10.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 25.0, 'partialScores': [{'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}], 'score': 5.0}, {'mutations': [{'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M41L', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M41L is a TAM that usually occurs with T215Y. In combination, M41L plus T215Y confer intermediate / high-level resistance to AZT and d4T and contribute to reduced ddI, ABC and TDF susceptibility.'}]}, {'text': 'T215Y', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'T215Y is a TAM that causes intermediate/high-level resistance to AZT and d4T, low-level resistance to ddI, and potentially low-level resistance to ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'G190S', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190S is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. Preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'G190S', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190S is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. Preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'G190S', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190S is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. Preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'G190S', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190S is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. Preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility.'}]}], 'score': 60.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'G190S', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'G190S is a non-polymorphic mutation that causes high-level resistance to NVP and EFV. It has a weight of 1.5 in the Tibotec ETR genotypic susceptibility score but does not appear to be selected by ETR or RPV or to reduce their in vitro susceptibility in the absence of other NNRTI-resistance mutations. Preliminary data suggests it is associated with low/intermediate reductions in DOR susceptibility.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}]}]"
{'header': 'AF252075.CB-316.B.98'},,[],"[{'firstAA': 1, 'lastAA': 228, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'D', 'position': 67, 'AAs': 'N', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': True}, {'consensus': 'T', 'position': 69, 'AAs': 'S', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'KR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 72, 'AAs': 'KR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 83, 'AAs': 'KR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 177, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'I', 'position': 178, 'AAs': 'M', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'M', 'position': 184, 'AAs': 'V', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'Q', 'position': 207, 'AAs': 'H', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 219, 'AAs': 'Q', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 60.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 20.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 55.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 40.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 70.0, 'partialScores': [{'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': 60.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'High-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}, {'mutations': [{'text': 'M184V', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ddI and ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication.'}]}], 'score': -10.0}, {'mutations': [{'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 5.0}, {'mutations': [{'text': 'D67N', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'D67N is a non-polymorphic TAM associated with low-level resistance to AZT and d4T. When present with other TAMs, it contributes reduced susceptibility to ABC, ddI, and TDF.'}]}, {'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}, {'text': 'K219Q', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K219Q/E are accessory TAMS associated with reduced susceptibility to AZT and possibly d4T.'}]}], 'score': 10.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}]}]"
{'header': 'AJ404357.LBJ15D_8.B.99'},,[],"[{'firstAA': 1, 'lastAA': 240, 'gene': {'name': 'RT', 'length': None}, 'mutations': [{'consensus': 'K', 'position': 11, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 20, 'AAs': 'R', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 70, 'AAs': 'KR', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'K', 'position': 101, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'D', 'position': 123, 'AAs': 'E', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'T', 'position': 200, 'AAs': 'I', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}, {'consensus': 'R', 'position': 211, 'AAs': 'K', 'isInsertion': False, 'isDeletion': False, 'isApobecDRM': False}]}]","[{'version': {'text': '8.8', 'publishDate': '2019-02-13'}, 'gene': {'name': 'RT'}, 'drugScores': [{'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'ABC', 'displayAbbr': 'ABC'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'AZT', 'displayAbbr': 'AZT'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'D4T', 'displayAbbr': 'D4T'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'DDI', 'displayAbbr': 'DDI'}, 'score': 10.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 10.0}], 'text': 'Potential Low-Level Resistance'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'FTC', 'displayAbbr': 'FTC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'LMV', 'displayAbbr': '3TC'}, 'score': 0.0, 'partialScores': [], 'text': 'Susceptible'}, {'drugClass': {'name': 'NRTI'}, 'drug': {'name': 'TDF', 'displayAbbr': 'TDF'}, 'score': 5.0, 'partialScores': [{'mutations': [{'text': 'K70R', 'primaryType': 'NRTI', 'comments': [{'type': 'NRTI', 'text': 'K70R causes intermediate resistance to AZT and possibly low-level resistance to D4T, DDI, ABC and TDF.'}]}], 'score': 5.0}], 'text': 'Susceptible'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'DOR', 'displayAbbr': 'DOR'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'K101E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'EFV', 'displayAbbr': 'EFV'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'K101E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'ETR', 'displayAbbr': 'ETR'}, 'score': 15.0, 'partialScores': [{'mutations': [{'text': 'K101E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility.'}]}], 'score': 15.0}], 'text': 'Low-Level Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'NVP', 'displayAbbr': 'NVP'}, 'score': 30.0, 'partialScores': [{'mutations': [{'text': 'K101E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility.'}]}], 'score': 30.0}], 'text': 'Intermediate Resistance'}, {'drugClass': {'name': 'NNRTI'}, 'drug': {'name': 'RPV', 'displayAbbr': 'RPV'}, 'score': 45.0, 'partialScores': [{'mutations': [{'text': 'K101E', 'primaryType': 'NNRTI', 'comments': [{'type': 'NNRTI', 'text': 'K101E is a non-polymorphic primarily accessory mutation that causes intermediate resistance to NVP and RPV, low-level resistance to EFV, and potentially low-level resistance to ETR. It has a weight of 1.0 in the Tibotec ETR genotypic susceptibility score. It is associated with low-level reductions in DOR susceptibility.'}]}], 'score': 45.0}], 'text': 'Intermediate Resistance'}]}]"
